| Trial ID: | L5384 |
| Source ID: | NCT03249259
|
| Associated Drug: |
Choline Alfoscerate
|
| Title: |
The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Choline alfoscerate|DRUG: Placebo
|
| Outcome Measures: |
Primary: Cognitive function, Change of MMSE Score, 6 months | Secondary: Glucose metabolism, Changes in HbA1c, 6 months|Glucose metabolism, Changes in fasting glucose concentration, 6 months | Other: Hypoglycemia, Incidence of hypoglycemia, 6 months
|
| Sponsor/Collaborators: |
Sponsor: Seoul National University Bundang Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2016-03-10
|
| Completion Date: |
2019-09-30
|
| Results First Posted: |
|
| Last Update Posted: |
2019-10-08
|
| Locations: |
Seoul National University Bundang Hospital, Seongnam, Gyeonggi, 463-707, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT03249259
|
